Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Will Ashworth

Moderna Is the Largest of Barchart’s Bottom 100 Stocks to Buy—But Size Alone Isn’t a Reason to Invest

It’s hard to believe Moderna (MRNA) once had a market cap exceeding $204 billion. That was in August 2021 at or near the height of the COVID-19 pandemic.  

As a result of Moderna possessing one of the leading global vaccines to beat back the virus, its valuation was 20x what it is today. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.